Capecitabine: Preclinical Pharmacology Studies
- 1 November 2000
- journal article
- review article
- Published by Springer Nature in Investigational New Drugs
- Vol. 18 (4) , 343-354
- https://doi.org/10.1023/a:1006497231579
Abstract
Capecitabine (N4-pentyloxycarbonyl-5′-deoxy-5-fluorocytidine) is a novel fluoropyrimidine carbamate, which was designed to besequentially converted to 5-fluorouracil (5-FU) by three enzymes located...Keywords
This publication has 33 references indexed in Scilit:
- Oral chemotherapy: rationale and future directions.Journal of Clinical Oncology, 1998
- Tumor Selective Delivery of 5-Fluorouracil by Capecitabine, a New Oral Fluoropyrimidine Carbamate, in Human Cancer XenograftsBiochemical Pharmacology, 1998
- Patient preferences for oral versus intravenous palliative chemotherapy.Journal of Clinical Oncology, 1997
- Cost of Treating Advanced Colorectal Cancer: A Retrospective Comparison of Treatment RegimensEuropean Journal Of Cancer, 1996
- Thymidine phosphorylase is angiogenic and promotes tumor growth.Proceedings of the National Academy of Sciences, 1995
- Interactions of interferon-α2a with 5′-deoxy-5-fluorouridine in colorectal cancer cells in vitroEuropean Journal Of Cancer, 1992
- Activation of 5'-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors.CHEMICAL & PHARMACEUTICAL BULLETIN, 1983
- 5'-DFUR, A NEW ANTI-CANCER AGENT ACTIVATED SELECTIVELY IN TUMOR-CELLS .2. COMPARATIVE STUDIES ON THE IMMUNOSUPPRESSIVE EFFECT AMONG 5'-DEOXY-5-FLUOROURIDINE, FTORAFUR, AND 5-FLUOROURACIL1980
- Purification and Properties of Cytidine Deaminase from Normal and Leukemic GranulocytesJournal of Clinical Investigation, 1974
- Studies of the enzymatic deamination of cytosine arabinoside—IBiochemical Pharmacology, 1965